Literature DB >> 30125606

Application of aptamers for in vivo molecular imaging and theranostics.

Alix Bouvier-Müller1, Frédéric Ducongé2.   

Abstract

Nucleic acid aptamers are small three-dimensional structures of oligonucleotides selected to bind to a target of interest with high affinity and specificity. In vitro, aptamers already compete with antibodies to serve as imaging probes, e.g. for microscopy or flow cytometry. However, they are also increasingly used for in vivo molecular imaging. Accordingly, aptamers have been evaluated over the last twenty years in almost every imaging modality, including single photon emission computed tomography, positron emission tomography, magnetic resonance imaging, fluorescence imaging, echography, and x-ray computed tomography. This review focuses on the studies that were conducted in vivo with aptamer-based imaging probes. It also presents how aptamers have been recently used to develop new types of probes for multimodal imaging and theranostic applications.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biodistribution; Imaging probes; In vivo imaging; Nanomedicine; SELEX

Mesh:

Substances:

Year:  2018        PMID: 30125606     DOI: 10.1016/j.addr.2018.08.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  17 in total

1.  Simultaneous probing of dual intracellular metabolites (ATP and paramylon) in live microalgae using graphene oxide/aptamer nanocomplex.

Authors:  Jee Young Kim; Cho Rok Jin; Jaewon Park; Dae Geun Kim; Hyun Soo Kim; Yoon-E Choi
Journal:  Mikrochim Acta       Date:  2022-02-07       Impact factor: 5.833

Review 2.  Enhancing CAR-T Cell Therapy with Functional Nucleic Acids.

Authors:  Bruktawit Maru; Lea Nadeau; Maureen McKeague
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-17

3.  RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.

Authors:  Ai-Ming Yu; Young Hee Choi; Mei-Juan Tu
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

Review 4.  Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders.

Authors:  Islauddin Khan; Kumari Preeti; Valencia Fernandes; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Cell Mol Neurobiol       Date:  2021-05-01       Impact factor: 4.231

5.  Citrate-assisted efficient local delivery of naked oligonucleotide into live mouse brain cells.

Authors:  Haibin Zhou; Shouhua Zhang; Fei Lv; Wenzhi Sun; Lihua Wang; Chunhai Fan; Jiang Li; Ji Hu
Journal:  Cell Prolif       Date:  2019-05-07       Impact factor: 6.831

6.  Characterization of Novel Aptamers Specifically Directed to Red-Spotted Grouper Nervous Necrosis Virus (RGNNV)-Infected Cells for Mediating Targeted siRNA Delivery.

Authors:  Lingli Zhou; Shaowen Wang; Qing Yu; Shina Wei; Mingzhu Liu; Jingguang Wei; Youhua Huang; Xiaohong Huang; Pengfei Li; Qiwei Qin
Journal:  Front Microbiol       Date:  2020-04-30       Impact factor: 5.640

Review 7.  Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors.

Authors:  Daniele E Mascarelli; Rhubia S M Rosa; Jessica M Toscaro; Isadora F Semionatto; Luciana P Ruas; Carolinne T Fogagnolo; Gabriel C Lima; Marcio C Bajgelman
Journal:  Front Cell Dev Biol       Date:  2021-06-30

Review 8.  Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach.

Authors:  Chris Vi; Giovanni Mandarano; Sarah Shigdar
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

Review 9.  Dendrimer- and polymeric nanoparticle-aptamer bioconjugates as nonviral delivery systems: a new approach in medicine.

Authors:  Serge Mignani; Xangyang Shi; Valentin Ceña; Jean-Pierre Majoral
Journal:  Drug Discov Today       Date:  2020-04-10       Impact factor: 7.851

Review 10.  Imaging of T-cells and their responses during anti-cancer immunotherapy.

Authors:  Massis Krekorian; Gilbert O Fruhwirth; Mangala Srinivas; Carl G Figdor; Sandra Heskamp; Timothy H Witney; Erik H J G Aarntzen
Journal:  Theranostics       Date:  2019-10-16       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.